SCHEMBL29317013

SCHEMBL29317013

O=C1Cc2c(ncc(F)c2Cl)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 5/20 0.37
KDR P35968 2/20 0.37
CDK5 Q00535 2/20 0.37
GSK3A P49840 2/20 0.37
GSK3B P49841 2/20 0.37
MET P08581 2/20 0.37
CHEK1 O14757 1/20 0.37
AURKA O14965 1/20 0.37
DAPK3 O43293 1/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
ABL1 P00519 1/20 0.37
NTRK1 P04629 1/20 0.37
CSF1R P07333 1/20 0.37
RET P07949 1/20 0.37
PDGFRB P09619 1/20 0.37
PIM1 P11309 1/20 0.37
PDGFRA P16234 1/20 0.37
FLT1 P17948 1/20 0.37
LTK P29376 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30057144 1.00 FGFR1 (0.37) FGFR1KDRCDK5GSK3AGSK3B
SCHEMBL27167139 0.77 CDK5 (0.36) FGFR1KDRCDK5GSK3AGSK3B
SCHEMBL24192115 0.75 CHEK1 (0.39) FGFR1KDRCDK5GSK3AGSK3B
SCHEMBL26326289 0.74 HTR2A (0.36) FGFR1KDRCDK5GSK3AGSK3B
SCHEMBL30368490 0.74 HTR2A (0.36) FGFR1KDRCDK5GSK3AGSK3B
SCHEMBL2782735 0.73 GSK3B (0.40) FGFR1KDRCDK5GSK3AGSK3B
SCHEMBL18721844 0.73 FGFR1 (0.36) FGFR1KDRCDK5GSK3AGSK3B
SCHEMBL24683458 0.71 SMYD3 (0.40) FGFR1KDRCDK5GSK3AGSK3B
SCHEMBL580431 0.69 CDK5 (0.47) FGFR1KDRCDK5GSK3AGSK3B
SCHEMBL260293 0.69 TNNI3K (0.39) FGFR1KDRCDK5GSK3AGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035367-A1 PKC-Theta Modulators CELGENE CORPORATION (US) 2026-02-05 US disclosed
US-20240239794-A1 PKC-Theta Modulators EXSCIENTIA AI LIMITED (GB) 2024-07-18 US disclosed
US-20240239794-A1 PKC-Theta Modulators EXSCIENTIA AI LIMITED (GB) 2024-07-18 US disclosed
US-20240239794-A1 PKC-Theta Modulators EXSCIENTIA AI LIMITED (GB) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239794-A1 PKC-Theta Modulators PRKCQ, PRKCH, PRKCZ FGFR1 4281/4885KDR 4131/4885CDK5 291/4885
US-20260035367-A1 PKC-Theta Modulators PRKAR2B, PRKAR2A, PRKCD FGFR1 3411/4885KDR 1648/4885CDK5 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.